Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
133,574,564
-
Share change
-
-8,242,952
-
Total reported value
-
$39,604,538,655
-
Put/Call ratio
-
136%
-
Price per share
-
$296.73
-
Number of holders
-
1,080
-
Value change
-
-$2,293,013,345
-
Number of buys
-
391
-
Number of sells
-
527
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q4 2019
As of 31 Dec 2019,
BIOGEN INC. - COM (BIIB) was held by
1,080 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,574,564 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, STATE STREET CORP, Clearbridge Investments, LLC, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, AQR CAPITAL MANAGEMENT LLC, NORTHERN TRUST CORP, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP.
This page lists
1,086
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.